These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8622853)

  • 1. New insights into p53 function from structural studies.
    Arrowsmith CH; Morin P
    Oncogene; 1996 Apr; 12(7):1379-85. PubMed ID: 8622853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific DNA binding by different classes of human p53 mutants.
    Rolley N; Butcher S; Milner J
    Oncogene; 1995 Aug; 11(4):763-70. PubMed ID: 7651740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of MAR/SAR DNA-elements by mutant p53.
    Müller BF; Paulsen D; Deppert W
    Oncogene; 1996 May; 12(9):1941-52. PubMed ID: 8649855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cellular protein activates the sequence-specific DNA-binding of p53 by interacting with the central conserved region.
    Srinivasan R; Maxwell SA
    Oncogene; 1996 Jan; 12(1):193-200. PubMed ID: 8552392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-specific interaction of a conformational domain of p53 with DNA.
    Srinivasan R; Roth JA; Maxwell SA
    Cancer Res; 1993 Nov; 53(22):5361-4. PubMed ID: 8221671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
    Hansen S; Lane DP; Midgley CA
    J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.
    Lubin DJ; Butler JS; Loh SN
    J Mol Biol; 2010 Jan; 395(4):705-16. PubMed ID: 19913028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tetramerization in p53 function.
    Chène P
    Oncogene; 2001 May; 20(21):2611-7. PubMed ID: 11420672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [P53 at the atomic scale: the multiple faces of a crystal].
    Hainaut P
    Bull Cancer; 1997 Jul; 84(7):747-51. PubMed ID: 9339202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 DNA binding can be modulated by factors that alter the conformational equilibrium.
    McLure KG; Lee PW
    EMBO J; 1999 Feb; 18(3):763-70. PubMed ID: 9927436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53 quaternary structure in relation to sequence-specific DNA binding.
    Hainaut P; Hall A; Milner J
    Oncogene; 1994 Jan; 9(1):299-303. PubMed ID: 8302593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation.
    Ishimaru D; Ano Bom AP; Lima LM; Quesado PA; Oyama MF; de Moura Gallo CV; Cordeiro Y; Silva JL
    Biochemistry; 2009 Jul; 48(26):6126-35. PubMed ID: 19505151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural aspects of the p53 protein in relation to gene evolution: a second look.
    Soussi T; May P
    J Mol Biol; 1996 Aug; 260(5):623-37. PubMed ID: 8709143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library.
    Kawaguchi T; Kato S; Otsuka K; Watanabe G; Kumabe T; Tominaga T; Yoshimoto T; Ishioka C
    Oncogene; 2005 Oct; 24(46):6976-81. PubMed ID: 16007150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain.
    Butler JS; Loh SN
    Biochemistry; 2003 Mar; 42(8):2396-403. PubMed ID: 12600206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of mutant p53 using field-effect transistor biosensor.
    Han SH; Kim SK; Park K; Yi SY; Park HJ; Lyu HK; Kim M; Chung BH
    Anal Chim Acta; 2010 Apr; 665(1):79-83. PubMed ID: 20381694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of RB18A, a 205 kDa new p53 regulatory protein which shares antigenic and functional properties with p53.
    Drané P; Barel M; Balbo M; Frade R
    Oncogene; 1997 Dec; 15(25):3013-24. PubMed ID: 9444950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Zn2+ on DNA recognition and stability of the p53 DNA-binding domain.
    Duan J; Nilsson L
    Biochemistry; 2006 Jun; 45(24):7483-92. PubMed ID: 16768444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of mutant p53: molecular mechanisms and therapeutic potential.
    Selivanova G; Wiman KG
    Oncogene; 2007 Apr; 26(15):2243-54. PubMed ID: 17401433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.